Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality

PLoS Genetics

Volumn 12, Issue 11, 2016, Pages

  Kulminski, Alexander M ^a   He, Liang ^a   Culminskaya, Irina ^a   Loika, Yury ^a   Kernogitski, Yelena ^a   Arbeev, Konstantin G ^a   Loiko, Elena ^a   Arbeeva, Liubov ^a   Bagley, Olivia ^a   Duan, Matt ^a   Yashkin, Arseniy ^a   Fang, Fang ^a   Kovtun, Mikhail ^a   Ukraintseva, Svetlana V ^a   Wu, Deqing ^a   Yashin, Anatoliy I ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACVR2A GENE; ADULT; AGE RELATED DISEASE; AGED; ALLELE; ARTICLE; CANCER RISK; CANDIDATE GENE METHOD; CARDIOVASCULAR RISK; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CHROMOSOME 2Q; CHROMOSOME 2Q22; CHROMOSOME BAND; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISEASES; ENDOPHENOTYPE; GENE; GENE CONTROL; GENE FREQUENCY; GENE LOCATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MIDDLE AGED; MORTALITY RISK; PLEIOTROPY; SINGLE NUCLEOTIDE POLYMORPHISM; ZEB2 GENE; ATHEROSCLEROSIS; CHROMOSOME 2; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC DISORDER; GENETICS; MALE; META ANALYSIS; MORTALITY; RISK FACTOR;

ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR TYPE II-A; HOMEODOMAIN PROTEIN; REPRESSOR PROTEIN; ZEB2 PROTEIN, HUMAN;

ACTIVIN RECEPTORS, TYPE II; ATHEROSCLEROSIS; CHROMOSOMES, HUMAN, PAIR 2; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC DISEASES, INBORN; GENETIC PLEIOTROPY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEART FAILURE; HOMEODOMAIN PROTEINS; HUMANS; MALE; REPRESSOR PROTEINS; RISK FACTORS; STROKE;

EID: 85000399291     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1006314     Document Type: Article

References (68)

1. Robine J-M, (2003) Determining health expectancies. Chichester, West Sussex, England; Hoboken, NJ, USA: Wiley. xiii, 428 p. p.
2. Manton KG, (1982) Changing concepts of morbidity and mortality in the elderly population. Milbank Mem Fund Q Health Soc60: 183–244. 6919770
3. Fries JF, (1980) Aging, natural death, and the compression of morbidity. N Engl J Med303: 130–135. doi: 10.1056/NEJM1980071730303047383070
4. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet38: 904–909. doi: 10.1038/ng184716862161
5. MacRae CA, Vasan RS, (2011) Next-generation genome-wide association studies: time to focus on phenotype?Circ Cardiovasc Genet4: 334–336. doi: 10.1161/CIRCGENETICS.111.96076521846867
6. Nesse RM, Ganten D, Gregory TR, Omenn GS, (2012) Evolutionary molecular medicine. J Mol Med (Berl)90: 509–522.
7. Oeppen J, Vaupel JW, (2002) Demography. Broken limits to life expectancy. Science296: 1029–1031. doi: 10.1126/science.106967512004104
8. Corella D, Ordovas JM, (2014) Aging and cardiovascular diseases: the role of gene-diet interactions. Ageing Res Rev18: 53–73. doi: 10.1016/j.arr.2014.08.00225159268
9. Kulminski AM, (2013) Unraveling genetic origin of aging-related traits: evolving concepts. Rejuvenation Res16: 304–312. doi: 10.1089/rej.2013.144123768105
10. Vijg J, Suh Y, (2005) Genetics of longevity and aging. Annu Rev Med56: 193–212. doi: 10.1146/annurev.med.56.082103.10461715660509
11. Crespi B, Stead P, Elliot M, (2010) Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia. Proc Natl Acad Sci U S A107Suppl 1: 1736–1741. doi: 10.1073/pnas.090608010619955444
12. Martin GM, (2012) Stochastic modulations of the pace and patterns of ageing: impacts on quasi-stochastic distributions of multiple geriatric pathologies. Mech Ageing Dev133: 107–111. doi: 10.1016/j.mad.2011.09.00121963385
13. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, et al. (2010) Common SNPs explain a large proportion of the heritability for human height. Nat Genet42: 565–569. doi: 10.1038/ng.60820562875
14. Ukraintseva S, Yashin A, Arbeev K, Kulminski A, Akushevich I, et al. (2016) Puzzling role of genetic risk factors in human longevity: "risk alleles" as pro-longevity variants. Biogerontology17: 109–127. doi: 10.1007/s10522-015-9600-126306600
15. Yashin AI, Wu D, Arbeev KG, Arbeeva LS, Akushevich I, et al. (2014) Genetic Structures of Population Cohorts Change with Increasing Age: Implications for Genetic Analyses of Human aging and Life Span. Ann Gerontol Geriatr Res1.
16. Yashin AI, Wu D, Arbeeva LS, Arbeev KG, Kulminski AM, et al. (2015) Genetics of aging, health, and survival: dynamic regulation of human longevity related traits. Front Genet6: 122. doi: 10.3389/fgene.2015.0012225918517
17. Day-Williams AG, Zeggini E, (2011) The effect of next-generation sequencing technology on complex trait research. Eur J Clin Invest41: 561–567. doi: 10.1111/j.1365-2362.2010.02437.x21155765
18. Kidambi S, Ghosh S, Kotchen JM, Grim CE, Krishnaswami S, et al. (2012) Non-replication study of a genome-wide association study for hypertension and blood pressure in African Americans. BMC Med Genet13: 27. doi: 10.1186/1471-2350-13-2722494468
19. Barabasi AL, Gulbahce N, Loscalzo J, (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet12: 56–68. doi: 10.1038/nrg291821164525
20. Zhu X, Feng T, Tayo BO, Liang J, Young JH, et al. (2015) Meta-analysis of correlated traits via summary statistics from GWASs with an application in hypertension. Am J Hum Genet96: 21–36. doi: 10.1016/j.ajhg.2014.11.01125500260
21. Kaeberlein M, Rabinovitch PS, Martin GM, (2015) Healthy aging: The ultimate preventative medicine. Science350: 1191–1193. doi: 10.1126/science.aad326726785476
22. Guarente L, (2011) Franklin H. Epstein Lecture: Sirtuins, aging, and medicine. N Engl J Med364: 2235–2244. doi: 10.1056/NEJMra110083121651395
23. Zhavoronkov A, Moskalev A, (2016) Editorial: Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives. Frontiers in Genetics7.
24. Franco OH, Karnik K, Osborne G, Ordovas JM, Catt M, et al. (2009) Changing course in ageing research: The healthy ageing phenotype. Maturitas63: 13–19. doi: 10.1016/j.maturitas.2009.02.00619282116
25. Sierra F, Hadley E, Suzman R, Hodes R, (2008) Prospects for Life Span Extension. Annu Rev Med.
26. Olshansky SJ, Perry D, Miller RA, Butler RN, (2007) Pursuing the longevity dividend: scientific goals for an aging world. Ann N Y Acad Sci1114: 11–13. doi: 10.1196/annals.1396.05017986572
27. Fisher RA, (1932) Statistical methods for research workers. Edinburgh,: Oliver and Boyd. xiii, 319 p. p.
28. Kulminski AM, Culminskaya I, Arbeev KG, Arbeeva L, Ukraintseva SV, et al. (2015) Birth Cohort, Age, and Sex Strongly Modulate Effects of Lipid Risk Alleles Identified in Genome-Wide Association Studies. PLoS One10: e0136319. doi: 10.1371/journal.pone.013631926295473
29. Graff M, Ngwa JS, Workalemahu T, Homuth G, Schipf S, et al. (2013) Genome-wide analysis of BMI in adolescents and young adults reveals additional insight into the effects of genetic loci over the life course. Hum Mol Genet22: 3597–3607. doi: 10.1093/hmg/ddt20523669352
30. Nygaard M, Lindahl-Jacobsen R, Soerensen M, Mengel-From J, Andersen-Ranberg K, et al. (2014) Birth cohort differences in the prevalence of longevity-associated variants in APOE and FOXO3A in Danish long-lived individuals. Exp Gerontol57: 41–46. doi: 10.1016/j.exger.2014.04.01824809632
31. Kulminski AM, Arbeev KG, Culminskaya I, Arbeeva L, Ukraintseva SV, et al. (2014) Age, gender, and cancer but not neurodegenerative and cardiovascular diseases strongly modulate systemic effect of the apolipoprotein e4 allele on lifespan. PLoS Genet10: e1004141. doi: 10.1371/journal.pgen.100414124497847
32. Kulminski AM, Culminskaya I, Arbeev KG, Ukraintseva SV, Stallard E, et al. (2013) The role of lipid-related genes, aging-related processes, and environment in healthspan. Aging Cell12: 237–246. doi: 10.1111/acel.1204623320904
33. Jarvik GP, Austin MA, Fabsitz RR, Auwerx J, Reed T, et al. (1994) Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effects. Genet Epidemiol11: 375–384. doi: 10.1002/gepi.13701104077813899
34. Atzmon G, Rincon M, Schechter CB, Shuldiner AR, Lipton RB, et al. (2006) Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biol4: e113. doi: 10.1371/journal.pbio.004011316602826
35. Yashin AI, De Benedictis G, Vaupel JW, Tan Q, Andreev KF, et al. (1999) Genes, demography, and life span: the contribution of demographic data in genetic studies on aging and longevity. Am J Hum Genet65: 1178–1193. doi: 10.1086/30257210486337
36. Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, et al. (2006) Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation113: 2914–2918. doi: 10.1161/CIRCULATIONAHA.106.61382816785337
37. Dugger BN, Malek-Ahmadi M, Monsell SE, Kukull WA, Woodruff BK, et al. (2016) A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases. Alzheimer Dis Assoc Disord.
38. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. (2001) The sequence of the human genome. Science291: 1304–1351. doi: 10.1126/science.105804011181995
39. Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, et al. (2005) Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature434: 724–731. doi: 10.1038/nature0346615815621
40. Ovcharenko I, Loots GG, Nobrega MA, Hardison RC, Miller W, et al. (2005) Evolution and functional classification of vertebrate gene deserts. Genome Res15: 137–145. doi: 10.1101/gr.301550515590943
41. Taylor J, (2005) Clues to function in gene deserts. Trends Biotechnol23: 269–271. doi: 10.1016/j.tibtech.2005.04.00315922077
42. Nobrega MA, Ovcharenko I, Afzal V, Rubin EM, (2003) Scanning human gene deserts for long-range enhancers. Science302: 413. doi: 10.1126/science.108832814563999
43. El-Kasti MM, Wells T, Carter DA, (2012) A novel long-range enhancer regulates postnatal expression of Zeb2: implications for Mowat-Wilson syndrome phenotypes. Hum Mol Genet21: 5429–5442. doi: 10.1093/hmg/dds38923001561
44. Erwin GD, Oksenberg N, Truty RM, Kostka D, Murphy KK, et al. (2014) Integrating diverse datasets improves developmental enhancer prediction. PLoS Comput Biol10: e1003677. doi: 10.1371/journal.pcbi.100367724967590
45. Bravo-Oro A, Lurie IW, Elizondo-Cardenas G, Pena-Zepeda C, Salazar-Martinez A, et al. (2015) A novel interstitial deletion of 2q22.3 q23.3 in a patient with dysmorphic features, epilepsy, aganglionosis, pure red cell aplasia, and skeletal malformations. Am J Med Genet A167A: 1865–1871. doi: 10.1002/ajmg.a.3680625988649
46. Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, et al. (2012) The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol302: F369–379. doi: 10.1152/ajprenal.00268.201122012804
47. Park SM, Gaur AB, Lengyel E, Peter ME, (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev22: 894–907. doi: 10.1101/gad.164060818381893
48. Beltran M, Puig I, Pena C, Garcia JM, Alvarez AB, et al. (2008) A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev22: 756–769. doi: 10.1101/gad.45570818347095
49. Katoh M, Katoh M, (2009) Integrative genomic analyses of ZEB2: Transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1alpha, POU/OCT, and NF-kappaB. Int J Oncol34: 1737–1742. 19424592
50. Weiss A, Attisano L, (2013) The TGFbeta superfamily signaling pathway. Wiley Interdiscip Rev Dev Biol2: 47–63. doi: 10.1002/wdev.8623799630
51. Wijayarathna R, de Kretser DM, (2016) Activins in reproductive biology and beyond. Hum Reprod Update.
52. Wilson M, Mowat D, Dastot-Le Moal F, Cacheux V, Kaariainen H, et al. (2003) Further delineation of the phenotype associated with heterozygous mutations in ZFHX1B. Am J Med Genet A119A: 257–265. doi: 10.1002/ajmg.a.2005312784289
53. Ballarati L, Recalcati MP, Bedeschi MF, Lalatta F, Valtorta C, et al. (2009) Cytogenetic, FISH and array-CGH characterization of a complex chromosomal rearrangement carried by a mentally and language impaired patient. Eur J Med Genet52: 218–223. doi: 10.1016/j.ejmg.2009.02.00419236961
54. Taylor J, (2001) Evolution of Gene Deserts in the Human Genome. eLS: John Wiley & Sons, Ltd.
55. Sharrett AR, (1992) The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component. Ann Epidemiol2: 467–469. 1342297
56. Govindaraju DR, Cupples LA, Kannel WB, O'Donnell CJ, Atwood LD, et al. (2008) Genetics of the Framingham Heart Study population. Adv Genet62: 33–65. doi: 10.1016/S0065-2660(08)00602-019010253
57. Splansky GL, Corey D, Yang Q, Atwood LD, Cupples LA, et al. (2007) The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol165: 1328–1335. doi: 10.1093/aje/kwm02117372189
58. Cupples LA, Heard-Costa N, Lee M, Atwood LD, (2009) Genetics Analysis Workshop 16 Problem 2: the Framingham Heart Study data. BMC Proc3Suppl 7: S3. 20018020
59. Lahoz C, Schaefer EJ, Cupples LA, Wilson PW, Levy D, et al. (2001) Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis154: 529–537. 11257253
60. Myers RH, Schaefer EJ, Wilson PW, D'Agostino R, Ordovas JM, et al. (1996) Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology46: 673–677. 8618665
61. Juster FT, Suzman R, (1995) An overview of the health and retirement study. Journal of Human Resources30: S7–S56.
62. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet81: 559–575. doi: 10.1086/51979517701901
63. Fisher RAS, (1970) Statistical methods for research workers. Edinburgh: Oliver and Boyd.
64. Prentice R, Breslow N, (1978) Retrospective studies and failure time models. Biometrika65: 153–158.
65. Shi G, Rice TK, Gu CC, Rao DC, (2009) Application of three-level linear mixed-effects model incorporating gene-age interactions for association analysis of longitudinal family data. BMC Proc3Suppl 7: S89. 20018085
66. Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, et al. (2009) Genomewide association studies of stroke. N Engl J Med360: 1718–1728. doi: 10.1056/NEJMoa090009419369658
67. Lange T, Vansteelandt S, Bekaert M, (2012) A simple unified approach for estimating natural direct and indirect effects. Am J Epidemiol176: 190–195. doi: 10.1093/aje/kwr52522781427
68. Robins JM, Hernan MA, Brumback B, (2000) Marginal structural models and causal inference in epidemiology. Epidemiology11: 550–560. 10955408